drugset

drugset / Trial / NCT00788528

Open-Label Extension (OLE) Study for Safety and Efficacy of Velneperit (S-2367) in Obese Subjects

NCT00788528 ↗

Phase 2 Completed 766 enrolled Shionogi

NaSingle-groupOpen-labelTreatment

Summary

The purpose of this open-label extension study is to evaluate the safety and efficacy of velneperit (S-2367) in obese subjects.

Timeline

Start: 2008-08
Primary completion: 2010-02
Completion: 2010-03

Drugs

Evaluation	Drug	Modality	Dose	Route
Subject	Velneperit	Small molecule	1600 mg	—

Indications